CD8A and Thrombocytopenia: The results of this study showed that compared with the control group, therapeutical effective rate, CD3, CD4, CD4/CD8, and ADRs in the treatment group were all improved, and the incidence of leukopenia and thrombocytopenia after chemotherapy were all reduced, with statistically significant differences.